Syringomycin E inhibition of Saccharomyces cerevisiae: requirement for biosynthesis of sphingolipids with very-long-chain fatty acids and mannose- and phosphoinositol-containing head groups
- PMID: 10770748
- PMCID: PMC89841
- DOI: 10.1128/AAC.44.5.1174-1180.2000
Syringomycin E inhibition of Saccharomyces cerevisiae: requirement for biosynthesis of sphingolipids with very-long-chain fatty acids and mannose- and phosphoinositol-containing head groups
Abstract
Syringomycin E is an antifungal cyclic lipodepsinonapeptide that inhibits the growth of Saccharomyces cerevisiae by interaction with the plasma membrane. A screen conducted to find the yeast genes necessary for its fungicidal action identified two novel syringomycin E response genes, SYR3 and SYR4. A syr3 mutant allele was complemented by ELO2 and ELO3. These genes encode enzymes that catalyze the elongation of sphingolipid very long chain fatty acids. Tetrad analysis showed that SYR3 was ELO2. Strains with deletions of SYR3/ELO2 and ELO3 were resistant to syringomycin E, and lipid analyses of both mutants revealed shortened fatty acid chains and lower levels of sphingolipids. SYR4 was identified by Tn5 inactivation of genomic library plasmids that complemented a syr4 mutant allele. SYR4 was found to be identical to IPT1, which encodes the terminal sphingolipid biosynthetic enzyme, mannosyl-diinositolphosphoryl-ceramide synthase. Deletion Deltasyr4/ipt1 strains were viable, were resistant to syringomycin E, did not produce mannosyl-diinositolphosphoryl-ceramide, and accumulated mannosyl-inositolphosphoryl-ceramide. Accumulation of mannosyl-inositolphosphoryl-ceramide was not responsible for resistance since a temperature-sensitive secretory pathway mutant (sec14-3(ts)) accumulated this sphingolipid and was sensitive to syringomycin E. Finally, Deltacsg1/sur1 and Deltacsg2 strains defective in the transfer of mannose to inositolphosphoryl-ceramide were resistant to syringomycin E. These findings show that syringomycin E growth inhibition of yeast is promoted by the production of sphingolipids with fully elongated fatty acid chains and the mannosyl and terminal phosphorylinositol moieties of the polar head group.
Figures
Similar articles
-
IPT1-independent sphingolipid biosynthesis and yeast inhibition by syringomycin E and plant defensin DmAMP1.FEMS Microbiol Lett. 2003 Jun 27;223(2):199-203. doi: 10.1016/S0378-1097(03)00375-6. FEMS Microbiol Lett. 2003. PMID: 12829286
-
Requirement of sphingolipid alpha-hydroxylation for fungicidal action of syringomycin E.FEBS Lett. 2000 Jul 28;478(1-2):26-8. doi: 10.1016/s0014-5793(00)01821-4. FEBS Lett. 2000. PMID: 10922463
-
SEC14-dependent secretion in Saccharomyces cerevisiae. Nondependence on sphingolipid synthesis-coupled diacylglycerol production.J Biol Chem. 1999 May 7;274(19):12979-83. doi: 10.1074/jbc.274.19.12979. J Biol Chem. 1999. PMID: 10224046
-
Yeast sphingolipids: metabolism and biology.Biochim Biophys Acta. 2002 Dec 30;1585(2-3):163-71. doi: 10.1016/s1388-1981(02)00337-2. Biochim Biophys Acta. 2002. PMID: 12531550 Review.
-
Yeast sphingolipids.Biochim Biophys Acta. 1999 Jan 6;1426(2):347-57. doi: 10.1016/s0304-4165(98)00135-4. Biochim Biophys Acta. 1999. PMID: 9878820 Review.
Cited by
-
The ER calcium channel Csg2 integrates sphingolipid metabolism with autophagy.Nat Commun. 2023 Jun 22;14(1):3725. doi: 10.1038/s41467-023-39482-6. Nat Commun. 2023. PMID: 37349354 Free PMC article.
-
Roles for sphingolipids in Saccharomyces cerevisiae.Adv Exp Med Biol. 2010;688:217-31. doi: 10.1007/978-1-4419-6741-1_15. Adv Exp Med Biol. 2010. PMID: 20919657 Free PMC article. Review.
-
Coordination of storage lipid synthesis and membrane biogenesis: evidence for cross-talk between triacylglycerol metabolism and phosphatidylinositol synthesis.J Biol Chem. 2011 Jan 21;286(3):1696-708. doi: 10.1074/jbc.M110.172296. Epub 2010 Oct 23. J Biol Chem. 2011. PMID: 20972264 Free PMC article.
-
Recovering Genomics Clusters of Secondary Metabolites from Lakes Using Genome-Resolved Metagenomics.Front Microbiol. 2018 Feb 20;9:251. doi: 10.3389/fmicb.2018.00251. eCollection 2018. Front Microbiol. 2018. PMID: 29515540 Free PMC article.
-
Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action.Antibiotics (Basel). 2023 Dec 11;12(12):1716. doi: 10.3390/antibiotics12121716. Antibiotics (Basel). 2023. PMID: 38136750 Free PMC article. Review.
References
-
- Altschul S F, Gish W, Miller W, Myers E W, Lipman D J. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. - PubMed
-
- Ballio A, Bossa F, Di Giorgio D, Ferranti P, Paci M, Scaloni A, Segre A, Strobel G. Novel bioactive lipodepsipeptides from Pseudomonas syringae: the pseudomycins. FEBS Lett. 1994;355:96–100. - PubMed
-
- Beeler T J, Fu D, Rivera J, Monaghan E, Gable K, Dunn T M. SUR1 (CSG1/BCL21), a gene necessary for growth of Saccharomyces cerevisiae in the presence of high Ca2+ concentrations at 37°C, is required for mannosylation of inositolphosphorylceramide. Mol Gen Genet. 1997;255:570–579. - PubMed
-
- Bull C T, Wadsworth M L, Sorensen K N, Takemoto J Y, Austin R K, Smilanick J L. Syringomycin E produced by biological control agents controls green mold on lemons. Biol Control. 1998;12:89–95.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
